We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,466

Supreme Court of Canada Bulletin - June 30, 2017
  • Gowling WLG
  • Canada
  • June 30 2017

On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638


International Trade Compliance Update - September 2016
  • Baker McKenzie
  • Australia, Canada, European Union, United Kingdom, USA
  • September 7 2016

On 19 August 2016, the Russian Federation notified the WTO that it intends to initiate negotiations pursuant to Paragraph 1143 of the Working Party


April 2017 International Trade Compliance Update
  • Baker McKenzie
  • Canada, European Union, United Kingdom, USA
  • April 12 2017

The WTO announced that WTO members discussed five new or enhanced proposals to advance services negotiations at meetings of the Working Party on


Supreme Court of Canada Promises New Utility Test for Patents
  • Blake Cassels & Graydon LLP
  • Canada
  • July 18 2017

What does “useful”, one of the basic requirements for the patentability of an invention, mean in Canadian patent law? On June 30, 2017, in


CIALIS Patent Survives Validity Challenge on Appeal
  • McCarthy Tétrault LLP
  • Canada
  • May 19 2016

Last year we wrote about a trilogy of Federal Court decisions relating to Eli Lilly’s erectile dysfunction (ED) drug CIALIS (tadalafil). While Lilly


Supreme Court holds that promises are not the yardstick to measure patent utility in Canada
  • Osler Hoskin & Harcourt LLP
  • Canada
  • July 4 2017

The Supreme Court of Canada issued its highly anticipated reasons in AstraZeneca v Apotex 2017 SCC 36. In its decision, the Supreme


Competitionantitrust law
  • Dentons
  • USA, Canada, China, European Union, Germany, OECD, United Kingdom, Australia
  • February 9 2017

In the wake of the 2016 elections, we now await the decision as to who will be the "antitrust guard" at the top of the US Department


Methods of medical treatment and dosage claims
  • Gowling WLG
  • Canada
  • June 28 2011

In Canada, claims to methods of medical treatment are considered to fall outside the definition of invention according to section 2 of the Patent Act and a decision of the Supreme Court of Canada


Global Government Solutions 2016: Mid-Year Outlook
  • K&L Gates
  • Australia, Canada, European Union, Germany, Global, United Kingdom, USA
  • July 1 2016

As we issue this 2016 Mid-Year Outlook, the global community has begun to wrestle in earnest with the momentous political, economic, and doing


Cialis Canadian Patent Knocks Out Double Patenting Challenge
  • Bereskin & Parr LLP
  • Canada
  • January 20 2017

Eli Lilly's Canadian patent on treatment of erectile dysfunction with Cialis continues to defy all challengers. A recent appeal case originated from